FDA Strengthens REMS for Transmucosal Immediate-Release Fentanyl Products
While the use of TIRF medications has declined in recent years, data have suggested that prescribing of these drugs to patients who are not opioid tolerant still remains.
While the use of TIRF medications has declined in recent years, data have suggested that prescribing of these drugs to patients who are not opioid tolerant still remains.
Researchers found a relationship between pain-related anxiety with pain intensity, interference, and the potential for opioid overuse.
As the diagnosis of opioid use disorder is often delayed or missed altogether, the researchers sought to test the utility of machine learning in creating a prediction model and algorithm for early diagnosis of OUD.
Patients already receiving opioid use disorder treatment continued to receive care during the early weeks of the COVID-19 pandemic, with some disruption to urine testing.
The number of individuals filling buprenorphine prescriptions for opioid use disorder has plateaued but not decreased during the COVID-19 pandemic.
In the early days of the COVID-19 pandemic, there was an increase in the number of patients receiving an outpatient buprenorphine prescription in Texas.
Schedule II opioids continue to be prescribed to high-risk patients 18 months after publication of the US Centers for Disease Control and Prevention guideline.
Opioid coprescription with psychotropic medications during pregnancy increases a woman’s antepartum hospitalization risk.
In 2018, polysubstance-involved opioid overdose deaths became more common than deaths involving opioids alone among US youth.
This study addresses the question of whether prescription opioid medications has a potentially causal role in the risk for depression and anxiety disorder.